share_log

南京威尔药业集团股份有限公司与中国银河证券股份有限公司关于南京威尔药业集团股份有限公司向不特定对象发行可转换公司债券申请文件的第二轮审核问询函的回复(修订稿)

Response from Nanjing Weil Pharmaceutical Group Co., Ltd. and China Galaxy Securities Co., Ltd. to the second round review inquiry letter of Nanjing Weil Pharmaceutical Group Co., Ltd. to issue convertible corporate bonds to unspecified targets (revised dr

SZSI ·  Jan 23, 2024 10:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more